Peregrine Pharmaceuticals, Inc. (PPHM) Posts Narrower than Expected Q1 Loss
PPHM Hot Sheet
EPS Growth %: +7.1%Financial Fact:
Interest and other expense: -6K
Today's EPS Names:
TARO, BRLI, TLB, More
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q1 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $5.66 million versus the consensus estimate of $2.17 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Tiffany & Co. (TIF) Misses Q1 EPS Views; Lowers FY12 EPS, Revs Growth Outlook
- VeriFone Systems (PAY) Tops Q2 EPS by 3c; Guides Q3, FY12
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
